NVDA vs NVMI

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.

Nova Ltd. exhibits strong fundamental health with a Piotroski F-Score of 7/9 and exceptional liquidity (Current Ratio 6.28), yet it faces a severe valuation disconnect. The current price of $517.43 is significantly higher than both the Graham Number ($86.52) and the growth-based Intrinsic Value ($236.59). While the company boasts a stellar 25-quarter earnings beat track record and strong profitability margins, the bearish insider sentiment and a very low technical trend score (10/100) suggest a potential peak. The stock is currently priced for perfection, leaving little margin for error despite its 'Strong Buy' analyst consensus.